Background/Aims: Arcuate nucleus (ARN) γ-aminobutyric acid (GABA) neurons are implicated in many critical homeostatic mechanisms, from food intake to fertility. To determine the functional relevance of ARN GABA neurons, it is essential to define the neurotransmitters co-expressed with and potentially co-released from ARN GABA neurons. Methods: The present study investigated the expression of markers of specific signaling molecules by ARN GABA neurons in brain sections from male, female, and, in some cases, prenatally androgen-treated (PNA) female, vesicular GABA transporter (VGaT)-ires-Cre/tdTomato reporter mice. Immunofluorescence for kisspeptin, β-endorphin, neuropeptide Y (NPY), tyrosine hydroxylase (TH) and neuronal nitric oxide synthase (nNOS) was detected by confocal microscopy, and co-localization with tdTomato VGaT reporter expression throughout the ARN was quantified. Results: GABA neurons rarely co-localized with kisspeptin (<2%) or β-endorphin (<1%), and only a small proportion of kisspeptin (∼10%) or β-endorphin (∼3%) neurons co-localized with VGaT in male and female mice. In contrast, one-third of ARN GABA neurons co-localized with NPY, and nearly all NPY neurons (>95%) co-localized with VGaT across groups. Both TH and nNOS labeling was co-localized with ∼10% of ARN GABA neurons. The proportion of TH neurons co-localized with VGaT was significantly greater in males than either control or PNA females, and the proportion of nNOS neurons co-localizing VGaT was higher in control and PNA females compared with males. Conclusion: These data highlight NPY as a significant subpopulation of ARN GABA neurons, demonstrate no significant impact of PNA on signal co-expression, and, for the first time, show sexually dimorphic co-expression patterns of TH and nNOS with ARN GABA neurons.

Keywords:
Neuropeptide Y, Nitric oxide synthase, Tyrosine hydroxylase, Kisspeptin, Polycystic ovary syndrome, Hypothalamus
1.
Kokay IC, Petersen SL, Grattan DR: Identification of prolactin-sensitive GABA and kisspeptin neurons in regions of the rat hypothalamus involved in the control of fertility. Endocrinology 2011;152:526-535.
2.
Zhang X, van den Pol AN: Dopamine/tyrosine hydroxylase neurons of the hypothalamic arcuate nucleus release GABA, communicate with dopaminergic and other arcuate neurons, and respond to dynorphin, Met-enkephalin, and oxytocin. J Neurosci 2015;35:14966-14982.
3.
Wu Q, Boyle MP, Palmiter RD: Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 2009;137:1225-1234.
4.
Krashes MJ, Shah BP, Koda S, Lowell BB: Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell Metab 2013;18:588-595.
5.
Martin C, Navarro VM, Simavli S, Vong L, Carroll RS, Lowell BB, Kaiser UB: Leptin-responsive GABAergic neurons regulate fertility through pathways that result in reduced kisspeptinergic tone. J Neurosci 2014;34:6047-6056.
6.
Zuure WA, Quennell JH, Anderson GM: Leptin responsive and GABAergic projections to the rostral preoptic area in mice. J Neuroendocrinol 2016;28:12357.
7.
Moore AM, Campbell RE: The neuroendocrine genesis of polycystic ovary syndrome: a role for arcuate nucleus GABA neurons. J Steroid Biochem Mol Biol 2016;160:106-117.
8.
Herbison AE: Physiology of the adult gonadotropin-releasing hormone neuronal network; in Plant TM, Zeleznik AJ (eds): Knobil and Neil's Physiology of Reproduction, ed 4. New York, Elsevier, 2015, vol 1, pp 399-468.
9.
Herbison AE, Pape JR: New evidence for estrogen receptors in gonadotropin-releasing hormone neurons. Front Neuroendocrinol 2001;22:292-308.
10.
Petersen SL, Ottem EN, Carpenter CD: Direct and indirect regulation of gonadotropin-releasing hormone neurons by estradiol. Biol Reprod 2003;69:1771-1778.
11.
Wintermantel TM, Campbell RE, Porteous R, Bock D, Grone HJ, Todman MG, Korach KS, Greiner E, Perez CA, Schutz G, Herbison AE: Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 2006;52:271-280.
12.
Smith ER, Davidson JM: Location of feedback receptors: effects of intracranially implanted steroids on plasma LH and LRF response. Endocrinology 1974;95:1566-1573.
13.
Akema T, Tadokoro Y, Kawakami M: Changes in the characteristics of pulsatile LH secretion after estradiol implantation into the preoptic area and the basal hypothalamus in ovariectomized rats. Endocrinol Jpn 1983;30:281-287.
14.
Yeo SH, Herbison AE: Estrogen-negative feedback and estrous cyclicity are critically dependent upon estrogen receptor-alpha expression in the arcuate nucleus of adult female mice. Endocrinology 2014;155:2986-2995.
15.
Moore AM, Prescott M, Marshall CJ, Yip SH, Campbell RE: Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome. Proc Natl Acad Sci USA 2015;112:596-601.
16.
Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE: Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:2248-2256.
17.
Yoo RY, Dewan A, Basu R, Newfield R, Gottschalk M, Chang RJ: Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril 2006;85:1049-1056.
18.
Burt Solorzano CM, Beller JP, Abshire MY, Collins JS, McCartney CR, Marshall JC: Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids 2012;77:332-337.
19.
Blank SK, McCartney CR, Marshall JC: The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 2006;12:351-361.
20.
Sullivan SD, Moenter SM: Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc Natl Acad Sci USA 2004;101:7129-7134.
21.
Moore AM, Prescott M, Campbell RE: Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. Endocrinology 2013;154:796-806.
22.
Hentges ST, Otero-Corchon V, Pennock RL, King CM, Low MJ: Proopiomelanocortin expression in both GABA and glutamate neurons. J Neurosci 2009;29:13684-13690.
23.
Meister B: Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 2007;92:263-271.
24.
Vong L, Ye C, Yang Z, Choi B, Chua S Jr, Lowell BB: Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron 2011;71:142-154.
25.
Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H: A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 2010;13:133-140.
26.
Wojcik SM, Katsurabayashi S, Guillemin I, Friauf E, Rosenmund C, Brose N, Rhee JS: A shared vesicular carrier allows synaptic corelease of GABA and glycine. Neuron 2006;50:575-587.
27.
Clarkson J, Herbison AE: Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons. Endocrinology 2006;147:5817-5825.
28.
Clifton VL, Telfer JF, Thompson AJ, Cameron IT, Teoh TG, Lye SJ, Challis JR: Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium. J Clin Endocrinol Metab 1998;83:3716-3721.
29.
Real MA, Heredia R, Labrador Mdel C, Davila JC, Guirado S: Expression of somatostatin and neuropeptide Y in the embryonic, postnatal, and adult mouse amygdalar complex. J Comp Neurol 2009;513:335-348.
30.
Lee KY, Lew JY, Tang D, Schlesinger DH, Deutch AY, Goldstein M: Antibodies to a synthetic peptide corresponding to a ser-40-containing segment of tyrosine hydroxylase: activation and immunohistochemical localization of tyrosine hydroxylase. J Neurochem 1989;53:1238-1244.
31.
Simonian SX, Herbison AE: Localization of neuronal nitric oxide synthase-immunoreactivity within sub-populations of noradrenergic A1 and A2 neurons in the rat. Brain Res 1996;732:247-252.
32.
Overgaard A, Tena-Sempere M, Franceschini I, Desroziers E, Simonneaux V, Mikkelsen JD: Comparative analysis of kisspeptin-immunoreactivity reveals genuine differences in the hypothalamic Kiss1 systems between rats and mice. Peptides 2013;45:85-90.
33.
Kloukina V, Herzer S, Karlsson N, Perez M, Daraio T, Meister B: G-protein-gated inwardly rectifying K+ channel 4 (GIRK4) immunoreactivity in chemically defined neurons of the hypothalamic arcuate nucleus that control body weight. J Chem Neuroanat 2012;44:14-23.
34.
Ciofi P, Crowley WR, Pillez A, Schmued LL, Tramu G, Mazzuca M: Plasticity in expression of immunoreactivity for neuropeptide Y, enkephalins and neurotensin in the hypothalamic tubero-infundibular dopaminergic system during lactation in mice. J Neuroendocrinol 1993;5:599-602.
35.
Fetissov SO, Byrne LC, Hassani H, Ernfors P, Hokfelt T: Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus. J Comp Neurol 2004;470:256-265.
36.
Sica M, Martini M, Viglietti-Panzica C, Panzica G: Estrous cycle influences the expression of neuronal nitric oxide synthase in the hypothalamus and limbic system of female mice. BMC Neurosci 2009;10:78.
37.
Cheong RY, Czieselsky K, Porteous R, Herbison AE: Expression of ESR1 in glutamatergic and GABAergic neurons is essential for normal puberty onset, estrogen feedback, and fertility in female mice. J Neurosci 2015;35:14533-14543.
38.
Cravo RM, Margatho LO, Osborne-Lawrence S, Donato J Jr, Atkin S, Bookout AL, Rovinsky S, Frazao R, Lee CE, Gautron L, Zigman JM, Elias CF: Characterization of Kiss1 neurons using transgenic mouse models. Neuroscience 2011;173:37-56.
39.
Qiu J, Nestor CC, Zhang C, Padilla SL, Palmiter RD, Kelly MJ, Ronnekleiv OK: High-frequency stimulation-induced peptide release synchronizes arcuate kisspeptin neurons and excites GnRH neurons. Elife DOI: 10.7554/eLife.16246.
40.
Nestor CC, Qiu J, Padilla SL, Zhang C, Bosch MA, Fan W, Aicher SA, Palmiter RD, Ronnekleiv OK, Kelly MJ: Optogenetic stimulation of arcuate nucleus Kiss1 neurons reveals a steroid-dependent glutamatergic input to POMC and AgRP neurons in male mice. Mol Endocrinol 2016;30:630-644.
41.
Abbara A, Ratnasabapathy R, Jayasena CN, Dhillo WS: The effects of kisspeptin on gonadotropin release in non-human mammals. Adv Exp Med Biol 2013;784:63-87.
42.
Radovick S, Levine JE, Wolfe A: Estrogenic regulation of the GnRH neuron. Front Endocrinol (Lausanne) 2012;3:52.
43.
Han SY, McLennan T, Czieselsky K, Herbison AE: Selective optogenetic activation of arcuate kisspeptin neurons generates pulsatile luteinizing hormone secretion. Proc Natl Acad Sci USA 2015;112:13109-13114.
44.
Yip SH, Boehm U, Herbison AE, Campbell RE: Conditional viral tract tracing delineates the projections of the distinct kisspeptin neuron populations to gonadotropin-releasing hormone (GnRH) neurons in the mouse. Endocrinology 2015;156:2582-2594.
45.
Williams DL, Schwartz MW: The melanocortin system as a central integrator of direct and indirect controls of food intake. Am J Physiol Regul Integr Comp Physiol 2005;289:R2-R3.
46.
Roa J, Herbison AE: Direct regulation of GnRH neuron excitability by arcuate nucleus POMC and NPY neuron neuropeptides in female mice. Endocrinology 2012;153:5587-5599.
47.
Jarvie BC, Hentges ST: Expression of GABAergic and glutamatergic phenotypic markers in hypothalamic proopiomelanocortin neurons. J Comp Neurol 2012;520:3863-3876.
48.
Horvath TL, Bechmann I, Naftolin F, Kalra SP, Leranth C: Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res 1997;756:283-286.
49.
Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001;411:480-484.
50.
Baquero AF, de Solis AJ, Lindsley SR, Kirigiti MA, Smith MS, Cowley MA, Zeltser LM, Grove KL: Developmental switch of leptin signaling in arcuate nucleus neurons. J Neurosci 2014;34:9982-9994.
51.
Diez-Guerra FJ, Bicknell RJ, Mansfield S, Emson PC, Dyer RG: Effect of neonatal testosterone upon opioid receptors and the content of beta-endorphin, neuropeptide Y and neurotensin in the medial preoptic and the mediobasal hypothalamic areas of the rat brain. Brain Res 1987;424:225-230.
52.
Horvath TL, Naftolin F, Kalra SP, Leranth C: Neuropeptide-y innervation of beta-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis. Endocrinology 1992;131:2461-2467.
53.
Liu X, Herbison AE: Dopamine regulation of gonadotropin-releasing hormone neuron excitability in male and female mice. Endocrinology 2013;154:340-350.
54.
Chen WP, Witkin JW, Silverman AJ: Gonadotropin releasing hormone (GnRH) neurons are directly innervated by catecholamine terminals. Synapse 1989;3:288-290.
55.
Horvath TL, Naftolin F, Leranth C: Luteinizing hormone-releasing hormone and gamma-aminobutyric acid neurons in the medial preoptic area are synaptic targets of dopamine axons originating in anterior periventricular areas. J Neuroendocrinol 1993;5:71-79.
56.
Leranth C, MacLusky NJ, Shanabrough M, Naftolin F: Catecholaminergic innervation of luteinizing hormone-releasing hormone and glutamic acid decarboxylase immunopositive neurons in the rat medial preoptic area. An electron-microscopic double immunostaining and degeneration study. Neuroendocrinology 1988;48:591-602.
57.
Simonian SX, Spratt DP, Herbison AE: Identification and characterization of estrogen receptor alpha- containing neurons projecting to the vicinity of the gonadotropin-releasing hormone perikarya in the rostral preoptic area of the rat. J Comp Neurol 1999;411:346-358.
58.
Szabadits E, Cserep C, Ludanyi A, Katona I, Gracia-Llanes J, Freund TF, Nyiri G: Hippocampal GABAergic synapses possess the molecular machinery for retrograde nitric oxide signaling. J Neurosci 2007;27:8101-8111.
59.
Crespo C, Gracia-Llanes FJ, Blasco-Ibanez JM, Gutierrez-Mecinas M, Marques-Mari AI, Martinez-Guijarro FJ: Nitric oxide synthase containing periglomerular cells are GABAergic in the rat olfactory bulb. Neurosci Lett 2003;349:151-154.
60.
Bellefontaine N, Hanchate NK, Parkash J, Campagne C, de Seranno S, Clasadonte J, d'Anglemont de Tassigny X, Prevot V: Nitric oxide as key mediator of neuron-to-neuron and endothelia-to-glia communication involved in the neuroendocrine control of reproduction. Neuroendocrinology 2011;93:74-89.
61.
Hernandez I, Parra A, Mendez I, Cabrera V, Cravioto MC, Mercado M, Diaz-Sanchez V, Larrea F: Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome. Arch Med Res 2000;31:216-222.
62.
Romualdi D, De Marinis L, Campagna G, Proto C, Lanzone A, Guido M: Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism. Clin Endocrinol (Oxf) 2008;69:562-567.
63.
Bidzinska-Speichert B, Lenarcik A, Tworowska-Bardzinska U, Slezak R, Bednarek-Tupikowska G, Milewicz A: Pro12Ala PPAR gamma2 gene polymorphism in PCOS women: the role of compounds regulating satiety. Gynecol Endocrinol 2012;28:195-198.
64.
Sheppard KM, Padmanabhan V, Coolen LM, Lehman MN: Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe. J Neuroendocrinol 2011;23:401-411.
65.
Yee CL, Wang Y, Anderson S, Ekker M, Rubenstein JL: Arcuate nucleus expression of NKX2.1 and DLX and lineages expressing these transcription factors in neuropeptide Y(+), proopiomelanocortin(+), and tyrosine hydroxylase(+) neurons in neonatal and adult mice. J Comp Neurol 2009;517:37-50.
66.
Mitkovski M, Padovan-Neto FE, Raisman-Vozari R, Ginestet L, da-Silva CA, Del-Bel EA: Investigations into potential extrasynaptic communication between the dopaminergic and nitrergic systems. Front Physiol 2012;3:372.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.